Table 1 Overview
Age (years), mean ± SD | 69 ±16 | |
Sex male, n (%) | 595 (58%) | |
Height (cm), mean ± SD | 170 ± 10 | |
Weight (kg), mean ± SD | 76 ± 18 | |
BMI (kg/m2), mean ± SD | 26 ± 5 | |
Serum creatinine (mmol/l), mean ± SD | 103 ± 63 | |
GFR CKD-EPI (ml/min), mean ± SD | 68 ± 27 | |
Indication for RXA, n (%) | Atrial fibrillation | 574 (56%) |
Pulmonary embolism | 128 (13%) | |
Thrombosis | 168 (16%) | |
Prophylaxis | 83 (8%) | |
Other | 74 (7%) | |
RXA dose (mg/day) (n = 1020) n (%) | 10 | 69 (7%) |
15 | 200 (20%) | |
20 | 712 (69%) | |
30 | 38 (4%) | |
40 | 1 (0%) | |
Quick (%), mean ± SD; median [IQR] | 76 ± 23; 77 [74–79] | |
INR, mean ± SD, median [IQR] | 1.3 ± 0.6; 1.2 [1.2–1.3] | |
aPTT (s), mean ± SD; median [IQR] | 30 ± 12; 28 [28–29] | |